FIELD: medicine; immunology.
SUBSTANCE: invention relates to immunology. Single-chain antibody to the cancer embryonic antigen, as well as a chimeric monomolecular T-cell receptor, a vector and a host cell for producing a chimeric monomolecular T-cell receptor are proposed.
EFFECT: this invention can find application in passive immunotherapy of oncological diseases.
5 cl, 6 dwg, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SINGLE-CHAIN ANTIBODY TO CARCINOEMBRYONIC ANTIGEN, CHIMERIC MONOMOLECULAR T-CELL RECEPTOR, VECTOR AND HOST CELL FOR PROVISION OF SUCH RECEPTOR AND METHOD OF DIAGNOSTICS OR TREATMENT | 2012 |
|
RU2522004C2 |
| MONOMOLECULAR CHIMERIC T-CELLULAR RECEPTOR TO CANCER-EMBRYONIC ANTIGEN | 2015 |
|
RU2652955C1 |
| MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
| METHOD OF DIRECTION OF CELLULAR IMMUNE RESPONSE AGAINST HIV-INFECTED MAMMALIAN CELL, PROTEIN MEMBRANE-BOUND CHIMERIC RECEPTOR, DNA | 1995 |
|
RU2173167C2 |
| METHOD OF SUPPRESSION OF HIV-INFECTED MAMMALIAN CELLS AND PROTEIN RECOMBINANT RECEPTOR FOR ITS REALIZATION | 1995 |
|
RU2165703C2 |
| REDIRECTION OF CELLULAR IMMUNITY BY CHIMERIC RECEPTORS | 1996 |
|
RU2167676C2 |
| LINE OF CELLS OF HUMAN MELANOMA KG, SECRETING RECOMBINANT GRANULOCYTIC MACROFAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2362805C1 |
| MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES WITH INCREASED CYTOTOXICITY | 2016 |
|
RU2772348C2 |
| NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER | 2020 |
|
RU2757353C1 |
| CELL THERAPY BASED ON IMPROVED NATURAL KILLER CELLS | 2017 |
|
RU2776890C2 |
